Antimalarials: Clinical Trials

5 trials for Antimalarials, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 1 Early Phase 1, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Early Phase 11Unknown 1
Phase 11Completed 1
Phase 31Completed 1

Follow Antimalarials: new trials by email Literature Review of Antimalarials trials Research Report on Antimalarials

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Practices for Treating Severe Malaria Caused by P. Falciparum
Malaria, Falciparum, Plasmodium Falciparum
CompletedCentre Hospitalier de Saint-Denis772024-05-012025-06-18
Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum
MMV367 3mg, P. falciparum IBSM infection, MMV367 5mg - Infections, Vector Borne Diseases
Phase 1CompletedMedicines for Malaria Venture122023-08-012025-12-10
Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals
Hydroxychloroquine Sulfate, Bromhexine 8 MG - Hydroxychloroquine, Antimalarials
Early Phase 1UnknownInstituto Nacional de Rehabilitacion2142021-02-012021-06-29
The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance
Falciparum Malaria, Antimalarials
CompletedTropical Medicine Research Institute1002006-10-012008-03-26
Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate to Amodiaquine in Colombia
Artesunate - Malaria,Falciparum, Malaria
Phase 3CompletedCentro Internacional de Entrenamiento e Investigaciones Médicas3602000-04-012006-09-20

Narrower conditions

Malaria, Falciparum (4)  ·  Malaria (2)  ·  COVID-19 (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Parasitemia (1)  ·  Parasitic Diseases (1)  ·  Pathologic Processes (1)  ·  Protozoan Infections (1)  ·  Systemic Inflammatory Response Syndrome (1)  ·  Vector Borne Diseases (1)

Broader conditions

Infections (4)  ·  Mosquito-Borne Diseases (4)  ·  Parasitic Diseases (3)  ·  Protozoan Infections (3)  ·  Vector Borne Diseases (3)  ·  Malaria (2)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)

Interventions

Artesunate (1)  ·  Bromhexine (1)  ·  Hydroxychloroquine (1)

Sponsors

Centre Hospitalier de Saint-Denis (1)  ·  Centro Internacional de Entrenamiento e Investigaciones Médicas (1)  ·  Instituto Nacional de Rehabilitacion (1)  ·  Medicines for Malaria Venture (1)  ·  Tropical Medicine Research Institute (1)

Countries

Australia (1)  ·  Colombia (1)  ·  France (1)  ·  Mexico (1)  ·  Sudan (1)

Top investigators

Badria B El-Sayed, PhD (1)  ·  Benoit Bestgen, PhD (1)  ·  Colin Sutherland, PhD. (1)  ·  Julio Granados-Montiel, MD, PhD (1)  ·  Lyda Osorio, MD PhD (1)

Results publications

PMID 18945956, PMID 25321315, PMID 27183377, PMID 28621712, PMID 32020029, PMID 32091533, PMID 32094336, PMID 32109013, PMID 32142651, PMID 32150618, PMID 32167747, PMID 32228809, PMID 32294342, PMID 32379955, PMID 32475230, PMID 33108255, PMID 33155953, PMID 33519466, PMID 33558079, PMID 34344672